Lumen Bioscience
Steven Landas has held various finance and accounting roles in the biotech industry, including Vice President, Finance & Corporate Controller at Cascadian Therapeutics, Inc. and Director of Accounting at Seattle Genetics. Currently serving as VP Finance and Controller at Lumen Bioscience, Steven Landas has a strong background in financial management and strategic planning. Landas obtained their education from the University of Washington.
This person is not in any teams
Lumen Bioscience
Lumen unlocks the full potential of biologic drugs, whose promise has been held back by the lack of scalable technology. Lumen's goal is to transform the way such drugs are developed, what they cost, and who has access to them.